Current and historical daily PE Ratio for Chong Kun Dang Pharmaceutical Corp (
) from 2013 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Chong Kun Dang Pharmaceutical stock (XKRX:185750) PE ratio as of Jun 09 2024 is 6.71.
More Details
Chong Kun Dang Pharmaceutical Corp (XKRX:185750) PE Ratio (TTM) Chart
Chong Kun Dang Pharmaceutical Corp (XKRX:185750) PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 1282
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Chong Kun Dang Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 6.7 | 2024-04-01 | 7.0 |
| 2024-06-07 | 6.7 | 2024-03-29 | 6.9 |
| 2024-06-05 | 6.7 | 2024-03-28 | 7.1 |
| 2024-06-04 | 6.8 | 2024-03-27 | 6.9 |
| 2024-06-03 | 6.5 | 2024-03-26 | 6.8 |
| 2024-05-31 | 6.6 | 2024-03-25 | 6.9 |
| 2024-05-30 | 6.4 | 2024-03-22 | 6.6 |
| 2024-05-29 | 6.6 | 2024-03-21 | 6.6 |
| 2024-05-28 | 6.9 | 2024-03-20 | 6.5 |
| 2024-05-27 | 6.8 | 2024-03-19 | 6.5 |
| 2024-05-24 | 6.7 | 2024-03-18 | 6.6 |
| 2024-05-23 | 6.3 | 2024-03-15 | 6.4 |
| 2024-05-22 | 6.3 | 2024-03-14 | 6.6 |
| 2024-05-21 | 6.4 | 2024-03-13 | 6.7 |
| 2024-05-20 | 6.4 | 2024-03-12 | 6.7 |
| 2024-05-17 | 6.5 | 2024-03-11 | 6.7 |
| 2024-05-16 | 6.5 | 2024-03-08 | 6.7 |
| 2024-05-14 | 6.5 | 2024-03-07 | 6.3 |
| 2024-05-13 | 6.4 | 2024-03-06 | 6.5 |
| 2024-05-10 | 6.5 | 2024-03-05 | 6.5 |
| 2024-05-09 | 6.5 | 2024-03-04 | 6.5 |
| 2024-05-08 | 6.5 | 2024-02-29 | 6.5 |
| 2024-05-07 | 6.5 | 2024-02-28 | 6.7 |
| 2024-05-03 | 6.4 | 2024-02-27 | 6.7 |
| 2024-05-02 | 6.5 | 2024-02-26 | 6.8 |
| 2024-04-30 | 6.6 | 2024-02-23 | 6.7 |
| 2024-04-29 | 6.7 | 2024-02-22 | 6.7 |
| 2024-04-26 | 6.4 | 2024-02-21 | 6.7 |
| 2024-04-25 | 6.3 | 2024-02-20 | 6.7 |
| 2024-04-24 | 6.4 | 2024-02-19 | 6.8 |
| 2024-04-23 | 6.5 | 2024-02-16 | 6.7 |
| 2024-04-22 | 6.4 | 2024-02-15 | 6.7 |
| 2024-04-19 | 6.2 | 2024-02-14 | 6.8 |
| 2024-04-18 | 6.4 | 2024-02-13 | 6.9 |
| 2024-04-17 | 6.2 | 2024-02-08 | 6.7 |
| 2024-04-16 | 6.3 | 2024-02-07 | 6.8 |
| 2024-04-15 | 6.3 | 2024-02-06 | 6.7 |
| 2024-04-12 | 6.5 | 2024-02-05 | 6.6 |
| 2024-04-11 | 6.4 | 2024-02-02 | 6.6 |
| 2024-04-09 | 6.5 | 2024-02-01 | 6.5 |
| 2024-04-08 | 6.5 | 2024-01-31 | 6.6 |
| 2024-04-05 | 6.5 | 2024-01-30 | 6.9 |
| 2024-04-04 | 6.6 | 2024-01-29 | 7.0 |
| 2024-04-03 | 6.7 | 2024-01-26 | 7.1 |
| 2024-04-02 | 6.8 | 2024-01-25 | 6.9 |
Chong Kun Dang Pharmaceutical Corp (XKRX:185750) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Chong Kun Dang Pharmaceutical Corp
ISIN : KR7185750007
Compare
Compare
Traded in other countries / regions
185750.Korea IPO Date
2013-12-06Description
Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers